🇪🇺 Remicade in European Union

EMA authorised Remicade on 13 August 1999

Marketing authorisations

EMA — authorised 13 August 1999

  • Local brand name: Remicade
  • Status: approved

EMA

  • Application: EMEA/H/C/002576
  • Local brand name: Remsima
  • Status: approved

Remicade in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Remicade approved in European Union?

Yes. EMA authorised it on 13 August 1999; EMA has authorised it.

Who is the marketing authorisation holder for Remicade in European Union?

Johnson & Johnson is the originator. The local marketing authorisation holder may differ — check the official source linked above.